As a leading operator of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy and other forms of treatment, The Center for Wound Healing, Inc. (OTC: CFWH) recently received a $17.5 million investment by Bison Capital Equity Partners II, LP. The company’s stock rose 34.48 percent on Tuesday, although the terms of the agreement have not been disclosed.
Douglas Trussler, a partner at Bison Capital commented on the recent investment, “We are extremely impressed with The Center for Wound Healings track record in operating wound care centers of excellence. The Company’s legacy of clinical outcomes and the strength of its hospital partner relationships are a testament to its commitment to the highest quality of care, coupled with highly professionalized operational management. Through our investment, The Center for Wound Healing will be able to expand the number of centers it develops and operates, furthering the tremendous benefit it provides to its hospital partners and their patients.”
Managing over 36 wound care centers in the eastern United States, The Center for Wound Healing works in partnership with local acute-care hospitals offering hyperbaric oxygen therapy. The center was founded by a group of physicians in 1997, with an emphasis on establishing in-hospital centers of excellence to treat the growing rate of severe-grade diabetic wounds, usually involving the lower extremities and wounds that are unresponsive to general wound-care treatment. The company’s wound centers have a reputation for providing and sustaining high end treatment success rates, thus increasing patient quality of life and contributing to cost savings to the healthcare system.
Andrew Barnett, CEO of The Center for Wound Healing, stated, “Bison exerted enormous time and effort to understand our business and the markets we serve. Eighty percent of the patients treated in the Company’s comprehensive wound care centers are diabetic; a population that today exceeds 20 million patients throughout the country and is growing by one million new patients per year. Bison has provided us with substantial long-term capital that will allow us to continue our expansion and provide superb care to this important demographic. We are delighted to have Bison Capital as a critical member of our team. We would also like to thank our shareholders for their support of the Company during this last year and look forward to continuing our efforts to serve a greater share of domestic wound care market.”
Let us hear your thoughts below:
